The early result shows that GA can prevent hepatic failure induced by lipopolysaccharide/D-galactosamine, reduce mortality and alanine aminotransferase (ALT)/aspartate aminotransferase (AST) elevation, and improve liver pathological injury. The gene discussed is GPT; the disease is Hepatic failure.